Novanta Inc. (NASDAQ:NOVT) CFO Robert Buckley Sells 4,108 Shares

Novanta Inc. (NASDAQ:NOVT) CFO Robert Buckley sold 4,108 shares of Novanta stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $172.75, for a total value of $709,657.00. Following the completion of the sale, the chief financial officer now directly owns 120,419 shares of the company’s stock, valued at $20,802,382.25. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Robert Buckley also recently made the following trade(s):

• On Tuesday, July 16th, Robert Buckley sold 1,830 shares of Novanta stock. The stock was sold at an average price of $180.18, for a total value of $329,729.40.
• On Friday, July 12th, Robert Buckley sold 1,830 shares of Novanta stock. The shares were sold at an average price of $170.19, for a total value of $311,447.70.
• On Monday, July 1st, Robert Buckley sold 1,830 shares of Novanta stock. The shares were sold at an average price of $161.09, for a total value of $294,794.70.

Novanta Stock Performance

Shares of Novanta stock traded down $6.19 on Monday, hitting $156.50. The stock had a trading volume of 272,159 shares, compared to its average volume of 139,939. Novanta Inc. has a twelve month low of $111.20 and a twelve month high of $187.12. The business’s 50 day moving average is $167.27 and its two-hundred day moving average is $165.25. The company has a quick ratio of 1.77, a current ratio of 2.83 and a debt-to-equity ratio of 0.75. The stock has a market cap of $5.62 billion, a price-to-earnings ratio of 84.30 and a beta of 1.31.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings results on Tuesday, May 7th. The technology company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.57 by $0.17. The firm had revenue of $230.92 million during the quarter, compared to the consensus estimate of $227.85 million. Novanta had a return on equity of 16.58% and a net margin of 7.76%. The business’s revenue was up 5.4% compared to the same quarter last year. During the same period last year, the business posted $0.74 EPS. Analysts forecast that Novanta Inc. will post 3.26 EPS for the current year.

Hedge Funds Weigh In On Novanta

Several hedge funds have recently modified their holdings of NOVT. Rise Advisors LLC purchased a new position in Novanta in the first quarter worth $32,000. First Horizon Advisors Inc. raised its stake in shares of Novanta by 67.5% during the fourth quarter. First Horizon Advisors Inc. now owns 211 shares of the technology company’s stock valued at $36,000 after acquiring an additional 85 shares during the last quarter. Headlands Technologies LLC bought a new position in Novanta in the first quarter worth about $52,000. Signaturefd LLC increased its stake in shares of Novanta by 38.3% during the second quarter. Signaturefd LLC now owns 361 shares of the technology company’s stock valued at $59,000 after purchasing an additional 100 shares in the last quarter. Finally, YHB Investment Advisors Inc. purchased a new stake in shares of Novanta during the first quarter valued at approximately $81,000. Institutional investors own 98.35% of the company’s stock.

Novanta Company Profile

Novanta Inc, together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.